Literature DB >> 9315635

Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.

E S Knudsen1, J Y Wang.   

Abstract

The growth suppression function of RB is dependent on its protein binding activity. RB contains at least three distinct protein binding functions: (i) the A/B pocket, which binds proteins with the LXCXE motif; (ii) the C pocket, which binds the c-Abl tyrosine kinase; and (iii) the large A/B pocket, which binds the E2F family of transcription factors. Phosphorylation of RB, which is catalyzed by cyclin-dependent protein kinases, inhibits all three protein binding activities. We have previously shown that LXCXE binding is inactivated by the phosphorylation of two threonines (Thr821 and Thr826), while the C pocket is inhibited by the phosphorylation of two serines (Ser807 and Ser811). In this report, we show that the E2F binding activity of RB is inhibited by two sets of phosphorylation sites acting through distinct mechanisms. Phosphorylation at several of the seven C-terminal sites can inhibit E2F binding. Additionally, phosphorylation of two serine sites in the insert domain can inhibit E2F binding, but this inhibition requires the presence of the RB N-terminal region. RB mutant proteins lacking all seven C-terminal sites and two insert domain serines can block Rat-1 cells in G1. These RB mutants can bind LXCXE proteins, c-Abl, and E2F even after they become phosphorylated at the remaining nonmutated sites. Thus, multiple phosphorylation sites regulate the protein binding activities of RB through different mechanisms, and a constitutive growth suppressor can be generated through the combined mutation of the relevant phosphorylation sites in RB.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315635      PMCID: PMC232425          DOI: 10.1128/MCB.17.10.5771

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  Identification of a growth suppression domain within the retinoblastoma gene product.

Authors:  X Q Qin; T Chittenden; D M Livingston; W G Kaelin
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

2.  Regions controlling hyperphosphorylation and conformation of the retinoblastoma gene product are independent of domains required for transcriptional repression.

Authors:  P A Hamel; R M Gill; R A Phillips; B L Gallie
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

3.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle.

Authors:  D W Goodrich; N P Wang; Y W Qian; E Y Lee; W H Lee
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

4.  Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering.

Authors:  D J Templeton; S H Park; L Lanier; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Hyperphosphorylation of the retinoblastoma gene product is determined by domains outside the simian virus 40 large-T-antigen-binding regions.

Authors:  P A Hamel; B L Cohen; L M Sorce; B L Gallie; R A Phillips
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

6.  Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product.

Authors:  W G Kaelin; M E Ewen; D M Livingston
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

7.  Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.

Authors:  S Chellappan; V B Kraus; B Kroger; K Munger; P M Howley; W C Phelps; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

8.  Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen.

Authors:  S Huang; N P Wang; B Y Tseng; W H Lee; E H Lee
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

9.  Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase.

Authors:  B T Lin; S Gruenwald; A O Morla; W H Lee; J Y Wang
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

10.  The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.

Authors:  J A Lees; K J Buchkovich; D R Marshak; C W Anderson; E Harlow
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  105 in total

1.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function.

Authors:  T T Chen; J Y Wang
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

3.  SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.

Authors:  X Lin; P Nelson; I H Gelman
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

4.  Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase.

Authors:  Z Sever-Chroneos; S P Angus; A F Fribourg; H Wan; I Todorov; K E Knudsen; E S Knudsen
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

5.  Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex.

Authors:  Peter W Lewis; Eileen L Beall; Tracey C Fleischer; Daphne Georlette; Andrew J Link; Michael R Botchan
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

6.  Phosphorylation puts the pRb tumor suppressor into shape.

Authors:  Andreas M F Heilmann; Nicholas J Dyson
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

7.  PNUTS knockdown potentiates the apoptotic effect of Roscovitine in breast and colon cancer cells.

Authors:  Gabriel De Leon; Margaret Cavino; Mikilyn D'Angelo; Nancy A Krucher
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

8.  Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer.

Authors:  Yoku Hayakawa; Yoshihiro Hirata; Hayato Nakagawa; Kei Sakamoto; Yohko Hikiba; Hiroto Kinoshita; Wachiko Nakata; Ryota Takahashi; Keisuke Tateishi; Motohisa Tada; Masao Akanuma; Haruhiko Yoshida; Kohsuke Takeda; Hidenori Ichijo; Masao Omata; Shin Maeda; Kazuhiko Koike
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

9.  BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.

Authors:  Kevin A Link; Craig J Burd; Erin Williams; Thomas Marshall; Gary Rosson; Erin Henry; Bernard Weissman; Karen E Knudsen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 10.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.